Renalytix Plc
RENXF
$0.02
-$0.01-35.66%
OTC PK
| 12/31/2025 | 09/30/2025 | 12/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -23.42M | -37.49M | -41.85M |
| Total Depreciation and Amortization | -- | -- | 29.00K | 224.00K | 285.00K |
| Total Amortization of Deferred Charges | -- | -- | 100.00K | 200.00K | 200.00K |
| Total Other Non-Cash Items | -- | -- | 5.40M | 4.07M | 3.89M |
| Change in Net Operating Assets | -- | -- | -5.10M | 2.07M | 1.32M |
| Cash from Operations | -- | -- | -22.99M | -30.92M | -36.16M |
| Capital Expenditure | -- | -- | -4.00K | -3.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 59.00K | 64.00K |
| Cash from Investing | -- | -- | -4.00K | 56.00K | 64.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -3.50M | -1.58M | -3.19M |
| Issuance of Common Stock | -- | -- | 32.03M | 5.31M | 20.53M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1.71M | -1.37M | -996.00K |
| Cash from Financing | -- | -- | 26.82M | 2.36M | 16.35M |
| Foreign Exchange rate Adjustments | -- | -- | -269.00K | 176.00K | 1.55M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 3.56M | -28.32M | -18.20M |